About Ready... Set... Evidence
Built to modernize evidence synthesis for medical device, biotech, and pharmaceutical teams working with real-world data.
Why Ready... Set... Evidence exists
Many evidence tools were designed around traditional literature review workflows, clean trial datasets, or highly specialized statistical use cases. Those tools can be valuable, but they often do not reflect how modern evidence teams actually work.
Clinical, regulatory, and post-market surveillance teams are increasingly asked to answer complex questions using mixed evidence sources: published studies, registries, complaint trends, utilization data, observational cohorts, internal performance datasets, and evolving real-world evidence.
That work is high stakes, time sensitive, and rarely tidy.
Designed for synthesis in the real world
Ready... Set... Evidence was created to help teams organize outcomes, compare cohorts, identify relevant signals, and generate defensible evidence summaries from real datasets, not just idealized ones.
The platform focus is practical evidence synthesis: bringing scattered data sources into one workflow, reducing spreadsheet sprawl, improving repeatability, and helping teams move from raw information to usable conclusions faster.
This includes support for controlled and uncontrolled evidence, observational data structures, and the types of messy inputs that often define real post-market and regulatory work.
Decisions are no longer driven only by a handful of controlled studies. Modern organizations need systems that can evaluate broader evidence landscapes, integrate real-world data, and support clear decision-making under regulatory scrutiny.
Built by practitioners
Ready... Set... Evidence was built by someone who has worked directly in clinical affairs, post-market surveillance, regulatory strategy, and evidence generation. The goal was straightforward: create the platform that evidence teams actually wished existed.
Less friction. Less manual rework. Better synthesis. Better decisions.
Where we are now
The current beta release is centered on the synthesis module, with additional workflow modules planned over time. Early users help shape priorities by showing where current evidence processes are slow, fragmented, or overly dependent on manual workarounds.